Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
10.03.25
/
50%
€4.21
Target price
10.03.26
€5.52
Performance (%)
17.02%
End price
11.03.26
€4.92
Summary
This prediction ended on 11.03.26 with a price of €4.92. The BUY prediction by SVB_Leerink_LLC finished with a performance of 17.02%. SVB_Leerink_LLC has a follow-up prediction for Xeris Biopharma Holdings Inc. where he still thinks Xeris Biopharma Holdings Inc. is a Buy. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | -1.497% | -1.497% | 45.382% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Leerink Partners from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten
Current prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.61
22.08.25
22.08.25
€7.75
22.08.26
22.08.26
-22.60%
16:57
16:57
